Taken together, these in vitro and previous in vitro/in vivo studies on NGF administration support the hypothesis that the purified NGF molecule represent a critical survival factor not only for RGC degeneration, as observed in Glaucoma and Maculopathy [21,38], but also for photoreceptor degeneration. The gene discussed is NGF; the disease is glaucoma.